Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer

BACKGROUND: Using antibody/aptamer-drug conjugates can be a promising method for decreasing toxicity, while increasing the efficiency of chemotherapy. METHODOLOGY/PRINCIPAL FINDINGS: In this study, the antitumor agent Doxorubicin (Dox) was incorporated into the modified DNA aptamer TLS11a-GC, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Ling, Yang, Liu, Zhao, Xiangxuan, Zhang, Lucy, Zhu, Haizhen, Liu, Chen, Tan, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338807/
https://www.ncbi.nlm.nih.gov/pubmed/22558072
http://dx.doi.org/10.1371/journal.pone.0033434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338807/
https://www.ncbi.nlm.nih.gov/pubmed/22558072
http://dx.doi.org/10.1371/journal.pone.0033434

Ejemplares similares